What are the consequences for patients with OA hemolytic disease?
Nov 14, 2023
Source: Cainiu Health
Dr. Liu Feng
Introduction
In general, OA hemolytic disease refers to one type of hemolytic disease in newborns, involving blood types O, A, and B. It is mostly caused by blood type incompatibility between mother and infant, leading to alloimmune hemolysis. Patients with OA hemolytic disease may experience consequences such as anemia, bone pain, liver dysfunction, splenic hyperfunction, and developmental disorders. If any discomfort occurs, prompt medical attention is necessary.
Generally, OA hemolytic disease refers to a type of hemolytic disease of the newborn involving blood types O, A, and B. It is mostly caused by blood type incompatibility between mother and child, leading to alloimmune hemolysis. Patients with OA hemolytic disease may experience consequences such as anemia, bone pain, liver dysfunction, hypersplenism, and developmental disorders. If discomfort occurs, prompt medical attention is necessary. Specific analyses are as follows:
1. Anemia
OA hemolytic disease causes excessive destruction of red blood cells. If not treated promptly, anemia may worsen. This occurs because the rate of red blood cell destruction exceeds the compensatory capacity of bone marrow hematopoiesis, resulting in anemia. Patients may experience symptoms such as dizziness and chest tightness; severe cases may lead to heart failure. It is recommended that patients take medications such as vitamin C tablets, folic acid tablets, and vitamin B12 tablets under medical supervision.
2. Bone Pain
Excess hemoglobin released from destroyed red blood cells can bind with iron in the bone marrow to form ferritin. Ferritin deposition in bones may cause bone pain and, in severe cases, fractures. It is recommended that patients use medications such as ibuprofen sustained-release capsules, loxoprofen sodium capsules, or enteric-coated aspirin tablets under medical guidance.
3. Liver Function Impairment
In OA hemolytic disease, red blood cell destruction produces large amounts of bilirubin, which may impair liver function and, in severe cases, lead to liver failure. Patients should ensure adequate rest and maintain a light diet. For impaired liver function, treatment may include medications such as compound glycyrrhizin tablets, glutathione tablets, or pitavastatin calcium tablets, as recommended by a physician.
4. Hypersplenism
Excessive destruction of red blood cells in the spleen may lead to hypersplenism, causing discomfort in the upper left abdomen and postprandial bloating. A diet consisting of light, easily digestible foods is recommended, avoiding greasy and irritating foods that may burden the spleen. Under medical guidance, splenectomy may be considered as a treatment option.
5. Developmental Disorders
If OA hemolytic disease occurs during fetal or infant stages, it may affect growth and development, potentially leading to delayed development or intellectual disability. Patients require active treatment of the underlying condition under medical supervision, with control of hemolytic reactions to prevent further deterioration.
Patients are advised to seek timely medical care when experiencing any discomfort and to follow standardized treatment under medical supervision, which helps promote recovery.
